| Bryanne E Fountain, | |
|
2500 Hall Avenue, Suite A, Marinette, WI 54143 | |
| (715) 732-7760 | |
| (715) 732-7711 |
| Full Name | Bryanne E Fountain |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 9 Years |
| Location | 2500 Hall Avenue, Marinette, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326214230 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 9013-123 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| County Of Marinette | 3476513177 | 2 |
News Archive
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
› Verified 1 days ago
| Entity Name | County Of Marinette |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134237480 PECOS PAC ID: 3476513177 Enrollment ID: O20041018000243 |
News Archive
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bryanne E Fountain, 2500 Hall Avenue, Suite A, Marinette, WI 54143 Ph: (715) 732-7760 | Bryanne E Fountain, 2500 Hall Avenue, Suite A, Marinette, WI 54143 Ph: (715) 732-7760 |
News Archive
Select patients with advanced prostate cancer may benefit from a Georgia Health Sciences University Cancer Center clinical trial that looks to improve survival rates of the FDA-approved prostate cancer drug Provenge.
A study led by University of Cincinnati lipid metabolism researchers lends additional insight into how bacteria in the gut, or lack thereof, influences intestinal mast cells (MMC) activation and perhaps fat absorption.
Serum procalcitonin is a useful marker for distinguishing between acute exacerbation of interstitial pneumonia and bacterial pneumonia, say researchers.
Savient Pharmaceuticals, Inc. announced that it has resubmitted its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for KRYSTEXXA™ (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
› Verified 1 days ago
Cheryl Krueger, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1602 Main St, Marinette, WI 54143 Phone: 715-735-9536 | |
Ashley Schutz, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2500 Hall Ave, Marinette, WI 54143 Phone: 715-732-7760 Fax: 715-732-7711 | |
Elizabeth J Jarvie, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Hall Ave Ste B, Marinette, WI 54143 Phone: 715-732-7793 Fax: 715-732-7667 | |
Wendy Therese Kahl, BS CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Hall Ave, Marinette County Health And Human Services Suite A, Marinette, WI 54143 Phone: 715-732-7700 Fax: 715-732-7766 | |
Tabitha Ann Fendrick, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Hall Ave, Marinette, WI 54143 Phone: 715-732-7700 Fax: 715-732-7667 | |
Christine Crane, LCSW LPC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2500 Hall Ave, Suite A Marinette County Health And Human Services, Marinette, WI 54143 Phone: 715-732-7760 Fax: 715-732-7711 |